{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T05:09:29Z","timestamp":1750828169391},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Pseudohypoparathyroidism (PHP) represents a heterogeneous group of rare endocrine disorders caused by (epi) genetic abnormalities affecting the GNAS locus. It is mainly characterized by resistance to PTH and TSH, and by peculiar clinical features such as short stature, obesity, cognitive impairment, subcutaneous ossifications and brachydactyly. Delayed puberty, GHRH and calcitonin resistances have also been described. The healthcare-pathway recently proposed by the Italian Society of Pediatric Endocrinology and Diabetology (ISPED) has provided a standardized clinical approach to these conditions. The purpose of the present study was to evaluate its application in clinical practice, and to collect data for setting future specific studies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Through a semi-structured survey, based on the indications of the care-pathway, data on PHP clinical management were collected. The compilation of each data in the survey was read as an index of the adoption of the healthcare-pathway in clinical practice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In addition to the proposing Center, 4 Centers joined the study, thus obtaining a large collection of data on 48 PHP patients. Highest rates in the completion of data were obtained for diagnostic history, auxological measurements and subcutaneous ossifications evaluation. As expected, the availability of data for the other investigated fields was lower, coming from recent research studies. More information has been obtained on hormonal resistance classically involved in PHP (PTH, TSH, GHRH and GnRH) and on cognitive impairment, while a few data has been collected on bone mineral status, calcitonin levels and glucolipid metabolism.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The presented data show that the ISPED healthcare-pathway could represent a valid tool both to confirm the clinical approach to PHP patients and to allow homogeneous data collection; however, it has not yet been fully adopted. The strengthening of the network among the major Italian Endocrine Centers will contribute to improve its application in clinical practice, optimizing the follow-up of these patients and increasing knowledge on PHP.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13052-021-01000-z","type":"journal-article","created":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T14:03:26Z","timestamp":1614866606000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pseudohypoparathyroidism: application of the Italian common healthcare-pathway for a homogeneous clinical approach and a shared follow up"],"prefix":"10.1186","volume":"47","author":[{"given":"Daniele","family":"Tessaris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Bonino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malgorzata","family":"Wasniewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Corica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Pitea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Scir\u00e8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Caruso-Nicoletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danilo","family":"Fintini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"de Sanctis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,4]]},"reference":[{"key":"1000_CR1","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1210\/jc.2009-0176","volume":"95","author":"G Mantovani","year":"2010","unstructured":"Mantovani G, de Sanctis L, Barbieri AM, Elli FM, Bollati V, Vaira V, et al. Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patients. J Clin Endocrinol Metab. 2010;95:651\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1000_CR2","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s11914-015-0268-x","volume":"13","author":"S Turan","year":"2015","unstructured":"Turan S, Bastepe M. GNAS Spectrum of disorders. Curr Osteoporos Rep. 2015;13(3):146\u201358.","journal-title":"Curr Osteoporos Rep"},{"issue":"1","key":"1000_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/humu.22696","volume":"36","author":"MC Lemos","year":"2015","unstructured":"Lemos MC, Thakker RV. GNAS mutations in pseudohypoparathyroidism type 1a and related disorders. Hum Mutat. 2015;36(1):11\u20139.","journal-title":"Hum Mutat"},{"issue":"10","key":"1000_CR4","first-page":"4622","volume":"86","author":"LS Weinstein","year":"2001","unstructured":"Weinstein LS. Editorial: the stimulatory g protein \u03b1-subunit gene: mutations and imprinting lead to complex phenotypes. J Clin Endocrinol Metab. 2001;86(10):4622\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1000_CR5","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1210\/jc.2016-3544","volume":"102","author":"A Usardi","year":"2017","unstructured":"Usardi A, Mamoune A, Nattes E, Carel JC, Rothenbuhler A, Linglart A. Progressive development of pth resistance in patients with inactivating mutations on the maternal allele of gnas. J Clin Endocrinol Metab. 2017;102(6):1844\u201350.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1000_CR6","doi-asserted-by":"publisher","first-page":"4336","DOI":"10.1210\/jc.2003-030393","volume":"88","author":"J Liu","year":"2003","unstructured":"Liu J, Erlichman B, Weinstein LS. The stimulatory G protein \u03b1-subunit Gs\u03b1 is imprinted in human thyroid glands: implications for thyroid function in pseudohypoparathyroidism types 1A and 1B. J Clin Endocrinol Metab. 2003;88(9):4336\u201341.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1000_CR7","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1515\/JPEM.2006.19.8.1049","volume":"19","author":"JE Pinsker","year":"2006","unstructured":"Pinsker JE, Rogers W, McLean S, Schaefer FV, Fenton C. Pseudohypoparathyroidism type 1a with congenital hypothyroidism. J Pediatr Endocrinol Metab. 2006;19(8):1049\u201352.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"1000_CR8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/BF03347406","volume":"30","author":"L de Sanctis","year":"2007","unstructured":"de Sanctis L, Bellone J, Salerno M, Faleschini E, Caruso-Nicoletti M, Cicchetti M, et al. GH secretion in a cohort of children with pseudohypoparathyroidism type la. J Endocrinol Investig. 2007;30(2):97\u2013103.","journal-title":"J Endocrinol Investig"},{"issue":"9","key":"1000_CR9","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1210\/jc.2003-030028","volume":"88","author":"EL Germain-Lee","year":"2003","unstructured":"Germain-Lee EL, Groman J, Crane JL, Jan De Beur SM, Levine MA. Growth hormone deficiency in pseudohypoparathyroidism type 1a: another manifestation of multihormone resistance. J Clin Endocrinol Metab. 2003;88(9):4059\u201369.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1000_CR10","doi-asserted-by":"publisher","first-page":"4070","DOI":"10.1210\/jc.2002-022028","volume":"88","author":"G Mantovani","year":"2003","unstructured":"Mantovani G, Maghnie M, Weber G, De Menis E, Brunelli V, Cappa M, et al. Growth hormone-releasing hormone resistance in Pseudohypoparathyroidism type Ia: new evidence for imprinting of the Gs\u03b1 gene. J Clin Endocrinol Metab. 2003;88(9):4070\u20134.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1000_CR11","first-page":"824","volume":"83","author":"AB Namnoum","year":"1998","unstructured":"Namnoum AB, Merriam GR, Moses AM, Levine MA. Reproductive dysfunction in women with Albright\u2019s hereditary Osteodystrophy 1. J Clin Endocrinol Metab. 1998;83(3):824\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1000_CR12","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1210\/jcem.86.7.7690","volume":"86","author":"V Vlaeminck-Guillem","year":"2001","unstructured":"Vlaeminck-Guillem V, D\u2019Herbomez M, Pigny P, Fayard A, Bauters C, Decoulx M, et al. Pseudohypoparathyroidism Ia and hypercalcitoninemia. J Clin Endocrinol Metab. 2001;86(7):3091\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1000_CR13","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1210\/jc.2013-1594","volume":"98","author":"R Muniyappa","year":"2013","unstructured":"Muniyappa R, Warren MA, Zhao X, Aney SC, Courville AB, Chen KY, et al. Reduced insulin sensitivity in adults with pseudohypoparathyroidism type 1a. J Clin Endocrinol Metab. 2013;98(11):1796\u2013801.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1000_CR14","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41574-018-0042-0","volume":"14","author":"G Mantovani","year":"2018","unstructured":"Mantovani G, Bastepe M, Monk D, De Sanctis L, Thiele S, Usardi A, et al. Diagnosis and management of pseudohypoparathyroidism and related disorders: first international consensus statement. Nat Rev Endocrinol. 2018;14(8):476\u2013500.","journal-title":"Nat Rev Endocrinol"},{"key":"1000_CR15","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1172\/JCI106149","volume":"48","author":"L Chase","year":"1969","unstructured":"Chase L, Melson G, Aurbach G. Defective excretion of 3\u2032, 5\u2032-AMP in response to parathyroid hormone. J Clin Invest. 1969;48:1832\u201344.","journal-title":"J Clin Invest"},{"issue":"20","key":"1000_CR16","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1056\/NEJM197311152892003","volume":"289","author":"M Drezner","year":"1973","unstructured":"Drezner M, Neelon FA, Lebovitz HE. Pseudohypoparathyroidism type II: a possible defect in the reception of the cyclic AMP signal. N Engl J Med. 1973;289(20):1056\u201360.","journal-title":"N Engl J Med"},{"issue":"6","key":"1000_CR17","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/MED.0b013e32835a255c","volume":"19","author":"MA Levine","year":"2013","unstructured":"Levine MA. An update on the clinical and molecular characteristics of pseudohypoparathyroidism. Curr opin endocrinol diabetes obes. 2013;19(6):443\u201351.","journal-title":"Curr opin endocrinol diabetes obes"},{"issue":"3","key":"1000_CR18","first-page":"922","volume":"30","author":"F Albright","year":"1942","unstructured":"Albright F, Burnett CH, Smith PH, Parson W. Pseudohypoparathyroidism - an example of \u2018Seabright-Bantam syndrome. Endocrinol. 1942;30(3):922\u201332.","journal-title":"Endocrinol."},{"issue":"10","key":"1000_CR19","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1210\/jc.2011-1048","volume":"96","author":"G Mantovani","year":"2011","unstructured":"Mantovani G. Pseudohypoparathyroidism: diagnosis and treatment. J Clin Endocrinol Metab. 2011;96(10):3020\u201330.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1000_CR20","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1210\/jc.2015-4310","volume":"101","author":"FM Elli","year":"2016","unstructured":"Elli FM, Linglart A, Garin I, De Sanctis L, Bordogna P, Grybek V, et al. The prevalence of GNAS deficiency-related diseases in a large cohort of patients characterized by the EuroPHP network. J Clin Endocrinol Metab. 2016;101(10):3657\u201368.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1000_CR21","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1055\/s-0032-1304232","volume":"44","author":"G Mantovani","year":"2012","unstructured":"Mantovani G, Elli FM, Spada A. GNAS epigenetic defects and pseudohypoparathyroidism: time for a new classification? Horm Metab Res. 2012;44(10):716\u201323.","journal-title":"Horm Metab Res"},{"issue":"6","key":"1000_CR22","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1530\/EJE-16-0107","volume":"175","author":"S Thiele","year":"2016","unstructured":"Thiele S, Mantovani G, Barlier A, Boldrin V, Bordogna P, De Sanctis L, et al. From pseudohypoparathyroidism to inactivating PTH\/PTHrP signalling disorder (iPPSD), a novel classification proposed by the EuroPHP network. Eur J Endocrinol. 2016;175(6):P1\u201317.","journal-title":"Eur J Endocrinol"},{"issue":"42(1)","key":"1000_CR23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13052-016-0310-3","volume":"21","author":"L de Sanctis","year":"2016","unstructured":"de Sanctis L, Giachero F, Mantovani G, Weber G, Salerno M, Baroncelli GI, et al. Genetic and epigenetic alterations in the GNAS locus and clinical consequences in Pseudohypoparathyroidism: Italian common healthcare pathways adoption. Ital J Pediatr. 2016;21(42(1)):101.","journal-title":"Ital J Pediatr"},{"key":"1000_CR24","unstructured":"Wechsler Intelligence Scale for Children (WISC) | Wechsler IQ Test.\u00a0https:\/\/wechsleriqtest.com\/wechsler-intelligence-scale-for-children\/"},{"key":"1000_CR25","unstructured":"Wechsler Adult Intelligence Scale (WAIS) | Wechsler IQ Test.\u00a0https:\/\/wechsleriqtest.com\/wechsler-adult-intelligence-scale\/"},{"issue":"5","key":"1000_CR26","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1002\/jbmr.2408","volume":"30","author":"A Molinaro","year":"2015","unstructured":"Molinaro A, Tiosano D, Takatani R, Chrysis D, Russell W, Koscielniak N, et al. TSH elevations as the first laboratory evidence for pseudohypoparathyroidism type Ib (PHP-Ib). J Bone Miner Res. 2015;30(5):906\u201312.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"1000_CR27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1365-2265.2007.03025.x","volume":"68","author":"M Mouallem","year":"2008","unstructured":"Mouallem M, Shaharabany M, Weintrob N, Shalitin S, Nagelberg N, Shapira H, et al. Cognitive impairment is prevalent in pseudohypoparathyroidism type Ia, but not in pseudopseudohypoparathyroidism: possible cerebral imprinting of Gs\u03b1. Clin Endocrinol. 2008;68(2):233\u20139.","journal-title":"Clin Endocrinol"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-021-01000-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13052-021-01000-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-021-01000-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T11:24:32Z","timestamp":1697973872000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-021-01000-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,4]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1000"],"URL":"https:\/\/doi.org\/10.1186\/s13052-021-01000-z","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,4]]},"assertion":[{"value":"25 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Local Ethics Committee; in the survey response patients\u2019 data were entered by each clinician anonymously.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all parents or legal guardians of patients included in the study. All Authors are responsible for correctness of the statements provided in the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}